Catheter Precision (VTAK) Change in Acquisitions & Divestments (2019 - 2020)

Catheter Precision's (VTAK) quarterly Change in Acquisitions & Divestments came in at $5.0 million in Q2 2020, down 54.55% on a QoQ basis from $11.0 million in Q1 2020.

Catheter Precision (VTAK) Change in Acquisitions & Divestments (2019 - 2020) Analysis & Trends

Catheter Precision (VTAK) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $5.0 million in Q2 2020.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $5.0 million in Q2 2020; TTM through Dec 2020 was $16.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $300000.0, changed N/A from the prior year.
  • Change in Acquisitions & Divestments for Q2 2020 stood at $5.0 million, down from $11.0 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for VTAK reached as high as $11.0 million in Q1 2020 and fell as low as $5.0 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.64 Bn 176.34 Bn 6.27 Bn
2 Stryker 129.04 Bn 126.16 Bn 3.81 Bn
3 Medtronic 109.04 Bn 99.82 Bn 6.41 Bn
4 Boston Scientific 68.54 Bn 67.08 Bn 3.61 Bn
5 Edwards Lifesciences 48.67 Bn 45.00 Bn 1.29 Bn
6 Dexcom 28.40 Bn 27.28 Bn 750.30 Mn
7 GE HealthCare Technologies 28.37 Bn 26.08 Bn 1.98 Bn
8 Smith & Nephew 26.92 Bn 26.34 Bn -
9 Koninklijke Philips 25.48 Bn 22.36 Bn 2.07 Bn
10 Catheter Precision 591,794.39 191,794.39 390,000.00

Historic Data

Download Data
DateValue
Jun 30, 2020 5.00 Mn
Jun 30, 2020 5.00 Mn
Mar 31, 2020 11.00 Mn
Mar 31, 2020 11.00 Mn
Dec 31, 2019 10.00 Mn
Dec 31, 2019 10.00 Mn